A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome.

Recruiting

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(2 sites)

China

The First Affiliated Hospital of Nanyang Medical College, Nanyang, Henan

Renji Hospital,Shanghai, Shanghai, Shanghai Municipality